Literature DB >> 2540987

Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements.

D P Brooks1, P F Koster, C R Albrightson, W F Huffman, M L Moore, F L Stassen, D B Schmidt, L B Kinter.   

Abstract

The vasopressin antidiuretic (V2) antagonist activity of the position 6 stereoisomers of four vasopressin analogs were tested for water diuretic activity in the rhesus monkey and for activity to inhibit vasopressin-stimulated adenylate cyclase activity in rhesus monkey and human renomedullary tissue in vitro. Replacement of the mercapto groups of the cysteine residues with methylene groups resulted in compounds having similar in vitro potencies to their disulfide analogs; however, these 'dicarba' compounds demonstrated more potent aquaretic activity. Position 6 D enantiomers were associated with less vasopressin antagonist activity in vitro in both species. Based upon these studies, the most potent aquaretic structure identified was the dicarba analog SK & F 105494.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540987     DOI: 10.1016/0014-2999(89)90666-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effect of cyclo-oxygenase blockade on the renal actions of vasopressin and SK&F 105494 in the rhesus monkey.

Authors:  D P Brooks; N C Caldwell; P F Koster; C R Albrightson-Winslow; L B Kinter
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

2.  Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

Authors:  A Ohnishi; Y Orita; R Okahara; H Fujihara; T Inoue; Y Yamamura; Y Yabuuchi; T Tanaka
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.